Ted Mathias serves as lead counsel in complex patent litigation, including cases involving more than 15 patents. He regularly handles litigation intersecting patent and antitrust law with a particular focus on advising clients in the pharmaceutical industry.
Lauded as an intellectual property “litigation star” by Benchmark Litigation, Ted represents clients in district courts across the country and before the U.S. Court of Appeals for the Federal Circuit. He has extensive experience representing patent owners and accused infringers of patents covering pharmaceuticals, medical devices, mechanical devices, e-commerce, and software. His practice includes litigating cases involving antitrust claims arising from patent disputes, standards setting, patent pooling, intellectual property licensing issues, and sham suits.
Ted notably served as lead counsel to a client who became the first party to survive summary judgment on a claim involving exclusionary rebating practices in the pharmaceutical industry. Regularly advising on patent remedies, he was part of an Axinn team that defended a $1.4 billion claim for a pharmaceutical client that settled following a two-week trial. He also successfully defended an $800 million trade secrets claim, obtaining summary judgment of no lost profits.
In addition to his trial work, Ted represents clients in private dispute resolution proceedings, mediations, and government investigations concerning antitrust, unfair competition, false advertising, and Internet privacy issues.
Ted is Chair of the American Bar Association Section of Intellectual Property Law’s Section 102/103 Subcommittee. Ted’s pro bono work includes defending prisoners’ rights in multiple cases, including class action litigations.
Updated Oct 2024
